英文摘要
|
This paper describes the nursing care experience of a newly diagnosed young female breast cancer patient who accepted the Neoadjuvant chemotherapy and target therapy. The nursing care period was from the 23th of November in 2016 to the 13th of April in 2017 with post-therapy following-up to date. The holistic nursing care was conducted by an oncology case manger to identify the nursing issues through interviews, observation and direct care. The primary finding revealed anxiety, body image disturbance, insufficient self protection etc. During the period of care, the individual, holistic and continuous care plan were established to alleviate the psychological impact and fear from the disease. The plan included encouraging patient to express her feelings, guiding her to proper emotional outlets, sharing the professional knowledge to diminish the physical discomfort from chemotherapy. Furthermore, to relieve the anxiety and worries about the treatments, the decision-making(SDM) tools were provided by medical team to help patient choose and accept appropriate treatment. Therefore, the patient accepted and treated the disease with a positive attitude by sharing her experience, adopted to the new body image after right side mastectomy and returned to a regular life. This nursing experience could provide peer nursing staff with a reference for caring for similar patients in the future.
|
参考文献
|
-
張美玉, M. Y.,徐莞雲, W. Y.,徐倩儀, C. Y.,林麗英, L. Y.(2016)。新診斷癌症病人生活品質之相關因素探討。榮總護理,33(3),293-302。
連結:
-
郭曉萱, H. H.,陳偉武, W. W.(2016)。HER2陽性轉移性乳癌治療新希望-從護理的觀點談賀癌寧(trastu- zumab emtansine)及其照護。護理護雜誌,65(5),121-126。
連結:
-
Hoekstra, R. A.,Heins, M. J.,Korevaar, J. C.(2014).Health care needs of cancer survivors in general practice: a systematic review.Bio Medicine Center Family Practice,15(1),94.
-
Oostra, D. R.,Macrae, E. R.(2014).Role of trastuzumab emtansine in the treatment of HER2-positive breast cancer.Breast Cancer: Targets and Therapy,6,103-113.
-
Schmid-Büchi, S.,Halfens, R. J. G.,Müller, M.,Dassen, T.,Van den Borne, B.(2013).Fac-tors associated with supportive care needs of patients under treatment for breast cancer.European Journal of Oncology Nursing,17(1),22-29.
-
林璟宏, C. H.(2013)。乳癌的化學治療。台灣醫學,17(4),404-411。
-
侯明鋒, M. F.,莊捷翰, C. H.(2016)。乳癌的最新治療。腫瘤護理雜誌,16(1),5-6。
-
洪敏瑛, M. Y.,邱文姿, W. T.,陳淑娟, S. C.,戴仕卿, S. C.,蕭逸美, Y. M.(2013)。癌症病人嗜中性白血球低下臨床照護指引-第二版修訂對照表。瘤護理雜誌,13(增訂刊),79-92。
-
張金堅, K. J.(2013)。化學治療的常見副作用—嗜中性白血球低下發燒。當代醫學,8(9),573-581。
-
張金堅, K. J.(2013)。乳癌先化療還是先開刀?談先導性化學治療。當代醫學,40(5),364-368。
-
張慎儀, S.Y.,胡文郁, W. Y.,翁開誠, K. C.,釋惠敏, H. M.(2014)。生命受威脅女性癌症病人生命故事之敘事研究。安寧療護雜誌,19(1),1-17。
-
馮欣蓓, H. P.,蕭妃秀, F. H.,賴佑銘, Y. M.,曾雯琦, W. C.(2013)。以文化觀點探討乳癌病人醫療照護需求。領導護理,14(4),2-10。
-
蔣秀容, S. R.,齊美婷, M. T.,王珮珩, P. H.,顧艷秋, Y. C.(2015)。初次罹患乳癌之求醫歷程。榮總護理,32(1),10-20。
-
衛生福利部(2017,7月30日).105年國人死因統計結果.取自http://www.mohw.gov.tw/cp-16-33598-1.html [Ministry of Health and Wel-fare. (2017, July 30). Cause of death statistics, 2016. Retrieved from http://www.mohw.gov.tw/cp-16-33598-1.html]
-
賴念華, N. H.(2015)。從表達性藝術治療於乳癌之文獻回顧探究在華人病友之應用。台灣藝術治療學刊,4(1),23-51。
|